Safety and Immunogenicity of Radiation-Attenuated PfSPZ Vaccine in Equatoguinean Infants, Children, and Adults
InfectologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- The American journal of tropical medicine and hygiene
- Publicado em
- 9 mai 2023
- Citações
- 11
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Safety and Immunogenicity of Radiation-Attenuated PfSPZ Vaccine in Equatoguinean Infants, Children, and Adults
Said A Jongo, Vicente Urbano Nsue Ndong Nchama, L W Preston Church, Ally Olotu, Stephen R Manock, Tobias Schindler, Ali Mtoro, Natasha Kc, Orrin Devinsky, Elcin Zan et al.
Descritores MeSH
- Malaria Vaccines
- Malaria, Falciparum
- Animals
- Child
- Child, Preschool
- Double-Blind Method
- Humans
- Infant
- Middle Aged
- Plasmodium falciparum
Veja também
Estudos relacionados
- Safety, tolerability and immunogenicity of a condensed, multi-dose prime regimen of PfSPZ Vaccine for the prevention of Plasmodium falciparum malaria infection
- Protective efficacy and safety of radiation-attenuated and chemo-attenuated Plasmodium Falciparum sporozoite vaccines against controlled and natural malaria infection: a systematic review and meta-analysis of randomized controlled trials
- Safety, tolerability, and protective efficacy of a radiation-attenuated, whole sporozoite malaria vaccine in children in Gabon: a randomised, double-blind, placebo-controlled, phase 2 trial
- Single immunization with genetically attenuated Pf∆mei2 (GA2) parasites by mosquito bite in controlled human malaria infection: a placebo-controlled randomized trial
- Primeiro ensaio em humanos em adultos de Burkinabe e crianças de vacina contra a malária PfSPZ-LARC2